Select Medical Holdings Yönetim
Yönetim kriter kontrolleri 1/4
Select Medical Holdings CEO'su David Chernow, Jan2014 tarihinde atandı, in görev süresi 10.83 yıldır. in toplam yıllık tazminatı $ 10.71M olup, şirket hissesi ve opsiyonları dahil olmak üzere 9.3% maaş ve 90.7% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.73% ine doğrudan sahiptir ve bu hisseler $ 35.79M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 1.1 yıl ve 14.5 yıldır.
Anahtar bilgiler
David Chernow
İcra Kurulu Başkanı
US$10.7m
Toplam tazminat
| CEO maaş yüzdesi | 9.3% |
| CEO görev süresi | 10.8yrs |
| CEO sahipliği | 0.7% |
| Yönetim ortalama görev süresi | 1.1yrs |
| Yönetim Kurulu ortalama görev süresi | 14.5yrs |
Son yönetim güncellemeleri
Recent updates
Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125
Nov 04
Returns Are Gaining Momentum At Select Medical Holdings (NYSE:SEM)
Oct 21Select Medical Holdings: No Reason To Downgrade This One Just Yet
Oct 07Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?
Oct 03Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125
Aug 05Select Medical Holdings' (NYSE:SEM) Returns On Capital Are Heading Higher
Jul 19What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?
Jul 01Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?
Jun 13There's Reason For Concern Over Select Medical Holdings Corporation's (NYSE:SEM) Price
May 26Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates
May 05Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely
Apr 19Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down
Apr 11Select Medical: Solid Growth Prospects And A Compelling Valuation
Mar 05Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely
Feb 18We Think Select Medical Holdings (NYSE:SEM) Is Taking Some Risk With Its Debt
Jan 15Returns On Capital At Select Medical Holdings (NYSE:SEM) Have Hit The Brakes
Dec 31Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125
Nov 06Select Medical: Market Expectations Appear Well Justified With Technical And Economic Factors
Oct 25What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?
Oct 04Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?
Sep 16Select Medical: Capital Charge Now $6.1Bn At C.6% Trailing Returns, Reiterate Hold
Aug 11Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125
Aug 07Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward
Jul 14At US$31.69, Is Select Medical Holdings Corporation (NYSE:SEM) Worth Looking At Closely?
Jun 29Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden
May 27Select Medical: Revising To Hold As Business Economics Roll Lower
May 26Select Medical Holdings (NYSE:SEM) May Have Issues Allocating Its Capital
Apr 05Should You Investigate Select Medical Holdings Corporation (NYSE:SEM) At US$25.73?
Mar 17Select Medical GAAP EPS of $0.22 misses by $0.11, revenue of $1.58B in-line
Feb 23Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden
Jan 31The Returns On Capital At Select Medical Holdings (NYSE:SEM) Don't Inspire Confidence
Dec 20Is Now An Opportune Moment To Examine Select Medical Holdings Corporation (NYSE:SEM)?
Dec 01CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$266m |
| Jun 30 2024 | n/a | n/a | US$259m |
| Mar 31 2024 | n/a | n/a | US$260m |
| Dec 31 2023 | US$11m | US$995k | US$235m |
| Sep 30 2023 | n/a | n/a | US$217m |
| Jun 30 2023 | n/a | n/a | US$196m |
| Mar 31 2023 | n/a | n/a | US$174m |
| Dec 31 2022 | US$9m | US$995k | US$153m |
| Sep 30 2022 | n/a | n/a | US$175m |
| Jun 30 2022 | n/a | n/a | US$223m |
| Mar 31 2022 | n/a | n/a | US$329m |
| Dec 31 2021 | US$12m | US$995k | US$389m |
| Sep 30 2021 | n/a | n/a | US$415m |
| Jun 30 2021 | n/a | n/a | US$415m |
| Mar 31 2021 | n/a | n/a | US$306m |
| Dec 31 2020 | US$8m | US$995k | US$250m |
| Sep 30 2020 | n/a | n/a | US$206m |
| Jun 30 2020 | n/a | n/a | US$162m |
| Mar 31 2020 | n/a | n/a | US$155m |
| Dec 31 2019 | US$8m | US$995k | US$143m |
| Sep 30 2019 | n/a | n/a | US$136m |
| Jun 30 2019 | n/a | n/a | US$138m |
| Mar 31 2019 | n/a | n/a | US$140m |
| Dec 31 2018 | US$8m | US$995k | US$133m |
| Sep 30 2018 | n/a | n/a | US$207m |
| Jun 30 2018 | n/a | n/a | US$193m |
| Mar 31 2018 | n/a | n/a | US$189m |
| Dec 31 2017 | US$7m | US$984k | US$171m |
Tazminat ve Piyasa: David 'nin toplam tazminatı ($USD 10.71M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 7.94M ).
Tazminat ve Kazançlar: David 'in maaşı son bir yılda %20'den fazla arttı.
CEO
David Chernow (67 yo)
10.8yrs
Görev süresi
US$10,706,265
Tazminat
Mr. David S. Chernow serves as Director at Exokinetics, Inc. He has been the Chief Executive Officer at Select Medical Holdings Corporation and Select Medical Corporation since January 1, 2014. Mr. Chernow...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 19.8yrs | US$10.77m | 6.94% $ 341.0m | |
| Chief Executive Officer | 10.8yrs | US$10.71m | 0.73% $ 35.8m | |
| Executive VP & CFO | 1.1yrs | US$1.53m | 0.13% $ 6.5m | |
| Senior Executive VP | 27.8yrs | US$4.44m | 0.34% $ 16.6m | |
| Senior Executive Vice President of Strategic Finance & Operations | 1.1yrs | US$6.47m | 0.99% $ 48.5m | |
| Co-President | 1.1yrs | Veri yok | 0.51% $ 25.1m | |
| Co-President | 1.1yrs | Veri yok | 0.24% $ 12.0m | |
| Senior VP | 1.7yrs | Veri yok | 0.027% $ 1.3m | |
| Executive VP & Chief Information Officer | 3.8yrs | Veri yok | 0.23% $ 11.5m | |
| Senior Vice President of Compliance & Audit | no data | Veri yok | 0.027% $ 1.3m | |
| Senior VP & Chief Communications | 1.1yrs | Veri yok | Veri yok | |
| Senior VP & Chief Human Resources Officer | 1.1yrs | Veri yok | Veri yok |
1.1yrs
Ortalama Görev Süresi
55yo
Ortalama Yaş
Deneyimli Yönetim: SEM 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.1 yıl), bu da yeni bir ekibin varlığını gösteriyor.
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 19.8yrs | US$10.77m | 6.94% $ 341.0m | |
| Independent Lead Director | 19.8yrs | US$384.40k | 0.85% $ 41.7m | |
| Independent Director | 20.8yrs | US$383.40k | 0.069% $ 3.4m | |
| Independent Director | 5.3yrs | US$405.80k | 0.051% $ 2.5m | |
| Independent Director | 14.5yrs | US$407.83k | 0.22% $ 10.9m | |
| Independent Director | 6yrs | US$394.40k | 0.042% $ 2.1m | |
| Independent Director | 16yrs | US$414.83k | 0.11% $ 5.6m | |
| Independent Director | 3.6yrs | US$409.80k | 0.036% $ 1.8m | |
| Independent Director | 3yrs | US$407.83k | 0.034% $ 1.7m |
14.5yrs
Ortalama Görev Süresi
66yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: SEM 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 14.5 yıldır).